(Q46067693)

19 December 2017

title

Identification of 12 or more lymph nodes in resected colon cancer specimens as an indicator of quality performance (English)

1 reference

19 December 2017

0 references

1 reference

Robert O Dillman

1

1 reference

19 December 2017

Kenneth Aaron

series ordinal

2

1 reference

19 December 2017

F Scott Heinemann

series ordinal

3

1 reference

19 December 2017

Stephanie E McClure

series ordinal

4

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 May 2009

1 reference

19 December 2017

published in

Cancer

1 reference

19 December 2017

volume

115

1 reference

19 December 2017

issue

9

1 reference

19 December 2017

page(s)

1840-1848

1 reference

19 December 2017

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Capecitabine as adjuvant treatment for stage III colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

A caution regarding lymphatic mapping in patients with colon cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: a population-based study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Impact of lymph node retrieval and pathological ultra‐staging on the prognosis of stage II colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Cancer staging and survival in colon cancer is dependent on the quality of the pathologists' specimen examination

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Detection of lymph node metastases in colorectal carcinoma before and after fat clearance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Cancer patient survival improvement is correlated with the opening of a community cancer center: comparisons with intramural and extramural benchmarks

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Influence of hospital procedure volume on outcomes following surgery for colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Operative treatment of colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Guidelines 2000 for colon and rectal cancer surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Lymph node evaluation and survival after curative resection of colon cancer: systematic review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24185

7 January 2021

Identifiers

DOI

10.1002/CNCR.24185

1 reference

19 December 2017

PubMed ID

19208427

1 reference

19 December 2017